XML 37 R24.htm IDEA: XBRL DOCUMENT
v3.25.2

Summary of Significant Accounting Policies (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Accounting Policies [Abstract] |
Schedules of Concentration of Risk, by Risk Factor | A significant customer is any biopharmaceutical customer, clinical testing payer, or international laboratory partner that represents 10% or more of the Company’s total revenue or accounts receivable balance. Revenue attributable to each significant customer, including its affiliated entities, as a percentage of the Company’s total revenue, for the respective period, and accounts receivable balance attributable to each significant customers, including its affiliated entities, as a percentage of the Company’s total accounts receivable balance, at the respective condensed consolidated balance sheet date, are as follows:
|  | Revenue |  | Accounts Receivable, Net
|  | Three Months Ended June 30, |  | Six Months Ended June 30, |  | June 30, 2025 |  | December 31, 2024
|  | 2025 |  | 2024 |  | 2025 |  | 2024 |
|  | (unaudited) |  | (unaudited) |  |
Customer A |  | * |  | 12 | % |  | * |  | * |  | 14 | % |  | 14 | %
Customer B |  | 28 | % |  | 29 | % |  | 28 | % |  | 30 | % |  | 10 | % |  | 12 | %
Customer C |  | * |  | * |  | * |  | * |  | 13 | % |  | 11 | %
* less than 10%
Schedule of Disaggregation of Revenue | The following table presents the Company’s revenue disaggregated by revenue source:
|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
|  | (unaudited)
|  | (in thousands)
Oncology |  | $ | 158,685 |  |  | $ | 130,269 |  |  | $ | 309,244 |  |  | $ | 256,017 |
Biopharma and data |  | 56,020 |  |  | 43,933 |  |  | 101,396 |  |  | 81,520 |
Screening |  | 14,814 |  |  | — |  |  | 20,491 |  |  | — |
Licensing and other |  | 2,569 |  |  | 3,033 |  |  | 4,428 |  |  | 8,189 |
Total revenue |  | $ | 232,088 |  |  | $ | 177,235 |  |  | $ | 435,559 |  |  | $ | 345,726 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration